To determine the reactive profiles of the prepared antibodies with tau in CSF, human CSF samples collected from probable CJD and non-CJD cases were employed into the Western blots reacting with the three prepared tau exon-specific antibodies and a commercial tau mAb Anti-Tau1. This evidence concerns the gene MAPT and Creutzfeldt Jacob disease.